Back
Thomson Reuters Vs. Nutex Health Industry Stock Comparison
Sell
50
TRI.TO
Thomson Reuters
Last Price:
235.81
Seasonality Move:
3.36%
Buy
78
NUTX
Nutex Health
Last Price:
32.61
Seasonality Move:
-16.36%
Sell
50
Thomson Reuters (TRI.TO)
is a Sell
Is Thomson Reuters a Buy, Sell or Hold?
- The current Thomson Reuters [TRI.TO] share price is $236.50. The Score for TRI.TO is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
- TRI.TO is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
78
Nutex Health (NUTX)
is a Buy
Is Nutex Health a Buy, Sell or Hold?
- The current Nutex Health [NUTX] share price is $37.56. The Score for NUTX is 78, which is 56% above its historic median score of 50, and infers lower risk than normal.
- NUTX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
TRI.TO Stock Price Chart
What is Thomson Reuters's stock price today?
-
The Thomson Reuters share price today is $236.50
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TRI.TO is experiencing selling pressure, which indicates risk of future bearish movement.
NUTX Stock Price Chart
What is Nutex Health's stock price today?
-
The Nutex Health share price today is $37.56
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NUTX is experiencing selling pressure, which indicates risk of future bearish movement.
TRI.TO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.28 | Buy |
| Relative Strength Index (14 RSI): | 59.24 | Buy |
| Chaikin Money Flow: | 204399 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
NUTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.63 | Buy |
| Relative Strength Index (14 RSI): | 74.06 | Buy |
| Chaikin Money Flow: | 232476 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
TRI.TO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 233.5 | Buy |
| 20-day SMA: | 232.02 | Buy |
| 50-day SMA: | 230.97 | Buy |
| 200-day SMA: | 222.91 | Buy |
| 8-day EMA: | 233.95 | Buy |
| 20-day EMA: | 232.38 | Buy |
| 50-day EMA: | 230.7 | Buy |
| 200-day EMA: | 220.28 | Buy |
NUTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 27.89 | Buy |
| 20-day SMA: | 25.02 | Buy |
| 50-day SMA: | 22.95 | Buy |
| 200-day SMA: | 13.95 | Buy |
| 8-day EMA: | 29.19 | Buy |
| 20-day EMA: | 25.9 | Buy |
| 50-day EMA: | 22.5 | Buy |
| 200-day EMA: | 24.44 | Buy |
Thomson Reuters Earnings Growth & TRI.TO Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.15 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.27 per share, and an increase next year of $0.44 per share.
Nutex Health Earnings Growth & NUTX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.54 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.42 per share, and an increase next year of $1.74 per share.
Thomson Reuters Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Nutex Health Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||